$1.65
Value $297M
Century TherapeuticsvsEli Lilly and Company
IPSC and LLY stock compared: price, dividend, valuation and results, from SEC filings.
+1.23%
$1,443.50
Value $1.36T
Century Therapeutics (IPSC) has a market value of $297M and Eli Lilly and Company (LLY) $1.36T. Over the last year, with dividends, IPSC moved +193.1% and LLY +42.9%. Dividend yield: IPSC none, LLY 0.44%.
At a glance
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
IPSC$297M
LLY$1.36T
LLY is 4,592 times IPSC
Revenue, 12 months
IPSC$109M
LLY$86.5B
LLY is 792 times IPSC
Net income, 12 months
IPSC-$99M
LLY$27.6B
Operating margin
IPSC-97.2%
LLY–
ROIC
IPSC-40.2%
LLY35.5%
75.7 points apart
P/E
IPSC–
LLY49.4
Dividend yield
IPSC0.0%
LLY0.4%
0.4 points apart
5-year return
IPSC-92.1%
LLY+480.4%
572.5 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
The price over time
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
IPSC-92.1%
LLY+480.4%
| Period | IPSCWith dividends | LLYWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +193.1%Price +193.1% | +42.9%Price +41.8% |
| 3 years since November 13, 2023 | +28.9%+8.8% a yearPrice +28.9% | +140.8%+34.0% a yearPrice +135.6% |
| 5 years since November 12, 2021 | -92.1%-39.8% a yearPrice -92.1% | +480.4%+42.2% a yearPrice +455.9% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
Every figure
As on each company's page. A description, not a recommendation: no one figure says which is better.
IPSCCentury TherapeuticsLLYEli Lilly and Company
Valuation
IPSCLLY| Price | $1.65 | $1,443.50 |
|---|---|---|
| Market value | $297M | $1.36T |
| Enterprise value (EV) | $179M | $1.41T |
| P/E | – | 49.4 |
| P/E, 5-year median | – | 49.9 |
| P/B | 1.4 | 33.8 |
| EV/EBIT | – | 40.5 |
| Free cash flow yield | – | 1.4% |
Results and growth
IPSCLLY| Revenue, 12 months | $109M | $86.5B |
|---|---|---|
| Net income, 12 months | -$99M | $27.6B |
| Free cash flow, 12 months | -$85M | $19.7B |
| Earnings per share, 12 months | -$0.64 | $30.81 |
| Revenue growth, year on year | 1,556.8% | 44.7% |
| Revenue growth a year, past | +175.9%over 3 years | +21.6%over 5 years |
| EPS growth a year, past | – | +27.6%over 5 years |
Margins and returns on capital
IPSCLLY| Gross margin | – | 83.6% |
|---|---|---|
| Operating margin | -97.2% | – |
| Net margin | -8.8% | 31.9% |
| ROIC | -40.2% | 35.5% |
| ROE | -47.4% | 88.6% |
Balance sheet
IPSCLLY| Cash | $117M | $4.9B |
|---|---|---|
| Total debt | $37M | $49.5B |
| Net debt / EBITDA | – | 1.2 |
| Interest cover | – | 38.9× |
Dividends and buybacks
IPSCLLY| Dividend yield | – | 0.4% |
|---|---|---|
| Dividend per share, 12 months | – | $6.34 |
| Dividend growth a year, past | – | +15.2%over 5 years |
| Buyback yield | – | 0.3% |
| Shareholder yield | – | 0.7% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
Which is bigger, Century Therapeutics or Eli Lilly and Company?
By market value, Eli Lilly and Company ($1.36T) is about 4,592.0 times Century Therapeutics ($297M), at today's prices.
How did IPSC and LLY stock do over the last 5 years?
Since November 12, 2021, IPSC's price moved -92.1% and LLY's +455.9%. With dividends: IPSC -92.1% (-39.8% a year), LLY +480.4% (+42.2% a year). Past returns do not predict future ones.
Which pays the higher dividend, IPSC or LLY?
The dividend yield at today's price is none for Century Therapeutics and 0.44% for Eli Lilly and Company. Over the last twelve months they paid – and $6.34 per share.
Which has the higher profit margins, Century Therapeutics or Eli Lilly and Company?
Over the last twelve months, the net margin was -8.8% for Century Therapeutics and 31.9% for Eli Lilly and Company, and the operating margin -97.2% and –. Revenue was $109M and $86.5B.
Which is the better investment, Century Therapeutics or Eli Lilly and Company?
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
Other comparisons
With each of the two, and with the largest in its sector.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.
Descriptive data from SEC filings and market prices.